Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
J Surg Oncol
    March 2024
  1. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    A national database analysis of the evolution of outcomes of surgery for anal melanoma.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
    >> Share

  2. STEADMAN JA, Glasgow AE, Neequaye NN, Habermann EB, et al
    Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27608.
    >> Share

  3. KADHUM M, Mayr L, Pope-Jones S, Cubitt J, et al
    Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27617.
    >> Share

    November 2023
  4. MALEKZADEH P, Brady MS
    Adjuvant therapy for stage IIB + IIC melanoma.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27534.
    >> Share

  5. KAKISH H, Lal T, Thuener JE, Bordeaux JS, et al
    Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
    J Surg Oncol. 2023 Nov 29. doi: 10.1002/jso.27543.
    >> Share

  6. GOYAL A, Fei-Zhang DJ, Pawlik TM, Bentrem DJ, et al
    Associations of social vulnerability with truncal and extremity melanomas in the United States.
    J Surg Oncol. 2023 Nov 27. doi: 10.1002/jso.27532.
    >> Share

  7. KAKISH H, Drigotas C, Ahmed FA, Elshami M, et al
    The effect of surgical timing in nonmetastatic melanoma.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27507.
    >> Share

  8. ASAI Y, Yanagawa N, Osakabe M, Yamada N, et al
    The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
    J Surg Oncol. 2023 Nov 2. doi: 10.1002/jso.27487.
    >> Share

    September 2023
  9. LIN X, Sun W, Ren M, Xu Y, et al
    Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
    J Surg Oncol. 2023 Sep 10. doi: 10.1002/jso.27438.
    >> Share

    July 2023
  10. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    >> Share

    April 2023
  11. ASARE EA, Fisher SB, Chiang YJ, Haydu LE, et al
    Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
    J Surg Oncol. 2023 Apr 3. doi: 10.1002/jso.27267.
    >> Share

    March 2023
  12. HOLTKAMP LHJ, Lo SN, Thompson JF, Spillane AJ, et al
    Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.
    J Surg Oncol. 2023 Mar 27. doi: 10.1002/jso.27245.
    >> Share

  13. SANTAMARIA-BARRIA JA, Matsuba C, Khader A, Scholar AJ, et al
    Age-related next-generation sequencing mutational analysis in 1196 melanomas.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27239.
    >> Share

  14. HOSEIN S, Drebin HM, Kurtansky NR, Olofsson Bagge R, et al
    Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231.
    >> Share

    December 2022
  15. LEONARD LD, Beaty L, Thomas M, Quinn C, et al
    Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma.
    J Surg Oncol. 2022 Dec 1. doi: 10.1002/jso.27153.
    >> Share

    November 2022
  16. LI WY
    The role of electrochemotherapy in dermal metastases.
    J Surg Oncol. 2022;126:1148.
    >> Share

    October 2022
  17. COIT DG, Ariyan CE
    Fifty years of progress in surgical oncology: Melanoma.
    J Surg Oncol. 2022;126:888-895.
    >> Share

    September 2022
  18. BAINVOLL L, Mandelbaum RS, Worswick SD, Matsuo K, et al
    Anatomical location of melanoma: A gender-specific analysis.
    J Surg Oncol. 2022 Sep 29. doi: 10.1002/jso.27111.
    >> Share

  19. MCKINLEY SK, Brady MS
    Neoadjuvant therapy for melanoma: A critical appraisal.
    J Surg Oncol. 2022 Sep 19. doi: 10.1002/jso.27089.
    >> Share

  20. LYNCH KT, Hu Y, Farrow NE, Song Y, et al
    Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
    J Surg Oncol. 2022 Sep 17. doi: 10.1002/jso.27100.
    >> Share

    July 2022
  21. STRAKER RJ, Tortorello GN, Sharon CE, Keele LJ, et al
    Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    J Surg Oncol. 2022 Jul 28. doi: 10.1002/jso.27021.
    >> Share

  22. MARSH KM, Lattimore CM, Cramer CL, Slingluff CL Jr, et al
    Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma.
    J Surg Oncol. 2022 Jul 23. doi: 10.1002/jso.27022.
    >> Share

  23. SALIM DN, Obinah MPB, Ternov NK, McCullagh MJD, et al
    Fine needle and core needle ultrasound guided biopsies for assessing suspected melanoma metastasis in lymph nodes and subcutaneous tissue.
    J Surg Oncol. 2022 Jul 6. doi: 10.1002/jso.26998.
    >> Share

    March 2022
  24. WHITMAN ED, Guenther JM
    RE: More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26775.
    >> Share

  25. YAN MK, Adler NR, Pan Y, Chamberlain A, et al
    Yield of baseline imaging for distant metastases in high-risk primary melanoma.
    J Surg Oncol. 2022 Mar 9. doi: 10.1002/jso.26846.
    >> Share

  26. MATSUO K, Nishio S, Ogata D, Kato T, et al
    Treatment specialty-specific characteristics and outcomes in women with vulvo-vaginal melanoma: A JGOG-JSCS joint study.
    J Surg Oncol. 2022 Mar 3. doi: 10.1002/jso.26835.
    >> Share

  27. CHAN BKY, Carrion-Alvarez L, Telfer R, Rehman AH, et al
    Surgical management of suspected gallbladder cancer: The role of intraoperative frozen section for diagnostic confirmation.
    J Surg Oncol. 2022;125:399-404.
    >> Share

  28. WITT RG, Cope B, Chiang YJ, Newhook T, et al
    Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.
    J Surg Oncol. 2022;125:719-729.
    >> Share

  29. ECKHOFF A, Farrow NE, Silvestri C, Stroobant E, et al
    How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent.
    J Surg Oncol. 2022;125:712-718.
    >> Share

    January 2022
  30. SHARIB J, Slingluff CL Jr, Beasley GM
    Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines.
    J Surg Oncol. 2022;125:28-33.
    >> Share

  31. FARIES MB
    Melanoma trials that defined surgical management.
    J Surg Oncol. 2022;125:34-37.
    >> Share

  32. PATEL A, Skitzki J
    Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.
    J Surg Oncol. 2022;125:38-45.
    >> Share

    December 2021
  33. YAN M, Rose PS, Houdek MT, Moran SL, et al
    Outcomes of the keystone perforator island flap for oncologic reconstruction of the back.
    J Surg Oncol. 2021;124:1002-1007.
    >> Share

    November 2021
  34. JAEGER ZJ, Williams GA, Chen L, Mhlanga JC, et al
    (18) F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.
    J Surg Oncol. 2021 Nov 6. doi: 10.1002/jso.26737.
    >> Share

  35. RENTROIA-PACHECO B, Tjien-Fooh FJ, Quattrocchi E, Kobic A, et al
    Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
    J Surg Oncol. 2021 Nov 4. doi: 10.1002/jso.26736.
    >> Share

    October 2021
  36. WEITEMEYER MB, Helvind NM, Brinck AM, Holmich LR, et al
    More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2021 Oct 21. doi: 10.1002/jso.26723.
    >> Share

    September 2021
  37. DUNNE JA, Adigbli G
    The changing landscape in management of desmoplastic melanoma.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26677.
    >> Share

  38. SUBRAMANIAN S, Han G, Olson N, Leong SP, et al
    Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26678.
    >> Share

  39. CORSINI EM, Mitchell KG, Zhou N, Bernatchez C, et al
    Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
    J Surg Oncol. 2021;124:699-703.
    >> Share

    August 2021
  40. DOWNS JS, Subramaniam S, Henderson MA, Paton E, et al
    A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.
    J Surg Oncol. 2021 Aug 18. doi: 10.1002/jso.26641.
    >> Share

    July 2021
  41. MULDER EEAP, Stahlie EHA, Verver D, Lemstra C, et al
    False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
    J Surg Oncol. 2021 Jul 8. doi: 10.1002/jso.26607.
    >> Share

    June 2021
  42. NARANG J, Hue JJ, Bingmer K, Hardacre JM, et al
    Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    J Surg Oncol. 2021 Jun 9. doi: 10.1002/jso.26565.
    >> Share

  43. DECKERS EA, Kruijff S, Bastiaannet E, van Ginkel RJ, et al
    Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
    J Surg Oncol. 2021 Jun 4. doi: 10.1002/jso.26555.
    >> Share

    March 2021
  44. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    >> Share

  45. THOMAS D, Bello DM
    Adjuvant immunotherapy for melanoma.
    J Surg Oncol. 2021;123:789-797.
    >> Share

    February 2021
  46. HUI JYC, Burke E, Broman KK, Marmor S, et al
    Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study.
    J Surg Oncol. 2021;123:646-653.
    >> Share

    December 2020
  47. HOUDEK MT, Honig RL, Mallett KE, Moran SL, et al
    Utility of toe fillet flaps for reconstruct of the forefoot in cases of plantar melanoma.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26348.
    >> Share

  48. BREDBECK BC, Mubarak E, Zubieta DG, Tesorero R, et al
    Management of the positive sentinel lymph node in the post-MSLT-II era.
    J Surg Oncol. 2020;122:1778-1784.
    >> Share

    November 2020
  49. PINERO-MADRONA A, Nicolas-Ruiz F, Rull-Ortuno R, Vidal-Sicart S, et al
    Correlation between ferromagnetic and isotopic tracers for sentinel lymph node detection in cutaneous melanoma: IMINEM study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26303.
    >> Share

  50. YAMASHITA TS, Pockaj BA, Bagaria SP, Flotte TJ, et al
    Clinical significance of SLN benign capsular nevi in patients with melanoma.
    J Surg Oncol. 2020;122:1043-1049.
    >> Share

    October 2020
  51. BLEICHER J, Swords DS, Mali ME, McGuire L, et al
    Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    J Surg Oncol. 2020 Oct 24. doi: 10.1002/jso.26214.
    >> Share

  52. LEE AY, Brady MS
    Neoadjuvant immunotherapy for melanoma.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26229.
    >> Share

  53. FRANKE V, Madu MF, Bierman C, Klop WMC, et al
    Challenges in sentinel node pathology in the era of adjuvant treatment.
    J Surg Oncol. 2020;122:964-972.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016